Baird Raises its Price Target on Healthpeak Properties (DOC)

Healthpeak Properties, Inc. (NYSE:DOC) is one of the 10 Fastest Growing S&P 500 Stocks to Buy Now.

On May 13, 2026, Baird analyst Wesley Golladay raised the firm’s price target on Healthpeak Properties, Inc. (NYSE:DOC) to $21 from $19 while maintaining an Outperform rating on the shares. The firm updated its model following the company’s Q1 results and improved outlook.

Meanwhile, Evercore ISI downgraded Healthpeak Properties, Inc. (NYSE:DOC) to In Line from Outperform and raised its price target to $21 from $20. The firm noted that while the quarter was complicated by the IPO of Janus Living, Healthpeak modestly increased its FY26 FFO guidance. Evercore added that the Q1 update drove a strong valuation rerating, leaving less upside potential in the shares following the recent move higher.

Earlier in May, Healthpeak Properties, Inc. (NYSE:DOC) reported net income of $0.28 per share, Nareit FFO of $0.42 per share, and FFO as Adjusted of $0.45 per share. The company also updated its FY26 guidance ranges, raising diluted earnings per common share guidance to $0.46-$0.50 from $0.34-$0.38 previously. Healthpeak also revised diluted Nareit FFO guidance to $1.68-$1.72 from $1.70-$1.74 and increased diluted FFO as Adjusted guidance to $1.71-$1.75 from $1.70-$1.74. The company reaffirmed its FY26 Total Same-Store Cash Adjusted NOI growth outlook of negative 1.0% to positive 1.0%.

Pixabay/Public Domain

Healthpeak Properties, Inc. (NYSE:DOC) is an S&P 500 real estate investment trust focused on owning, operating, and developing healthcare-related properties across the United States.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.